After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Yahoo Finance discussed the stock recently as it posted Neurocrine Biosciences Reports Fourth Quarter and Fiscal 2023 Financial Results and Provides Financial Expectations for 2024.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
The company is listed on the NASDAQ and operates within the Drug Manufacturers – Specialty & Generic industry segment. At the end of the last regular session, the stock closed at $132.65 and fluctuated between $134.16 as its day high and $131.59 as its day low. The current market capitalization of Neurocrine Biosciences, Inc. is $13.20B. A total of 0.81 million shares were traded on the day, compared to an average of 789.80K shares.
Insider Activity
Furthermore, investors take into consideration insider trades when predicting a stock’s future trajectory. During the recent three months, NBIX has seen 2 BUY and 4 SELL insider trades, representing the acquisition of 24,000 and the disposition of 44,000 shares. Over the last 12 months, there were 7 BUYs and 28 SELLs from insiders. Insiders purchased 54,000 shares during that period but sold 127,917.
In the most recent transaction, GORMAN KEVIN CHARLES sold 2,832 shares of NBIX for 133.02 per share on Feb 13. After the transaction, the Chief Executive Officer now owns 514,596 company shares. In a previous transaction on Feb 13, Boyer David W. sold 1,811 shares at 133.07 per share. NBIX shares that Chief Corp. Affairs Officer owns now total 4,895.
Among the insiders who sold shares, Onyia Jude disposed of 1,432 shares on Feb 13 at a per-share price of $132.94. This resulted in the Chief Scientific Officer holding 13,128 shares of NBIX after the transaction. In another insider transaction, Gano Kyle sold 1,352 shares at $132.89 per share on Feb 13. Company shares held by the Chief Business Development Off now total 135,166.
It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. According to analysts who have offered 12-month price targets for NBIX in the last 3 months, the mean price target is $149.26 with high estimates of $170.00 and low estimates of $106.00. In terms of 52-week highs and lows, NBIX has a high of $143.35 and a low of $89.04.
As of this writing, NBIX has an earnings estimate of $0.98 per share for the current quarter. EPS was calculated based on a consensus of 17 estimates, with a high estimate of $1.77 per share and a lower estimate of $0.21. The company reported an EPS of $0.82 in the last quarter, which was -15.50% lower than expectations of $0.97.
Balance Sheet Annually/Quarterly
An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information. NBIX’s latest balance sheet shows that the firm has $711.30M in Cash & Short Term Investments as of fiscal 2021. There were $440.40M in debt and $245.80M in liabilities at the time. Its Book Value Per Share was $22.61, while its Total Shareholder’s Equity was $1.37B.
Analysts Opinion
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for NBIX is Buy with a score of 4.50.
